Back to Search Start Over

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal.

Authors :
Pons-Estel BA
Sánchez-Guerrero J
Romero-Díaz J
Iglesias-Gamarra A
Bonfa E
Borba EF
Shinjo SK
Bernatsky S
Clarke A
García MA
Marcos JC
Duarte A
Berbotto GA
Scherbarth H
Marques CD
Onetti L
Saurit V
Souza AW
Velozo E
Catoggio LJ
Neira O
Burgos PI
Ramirez LA
Molina JF
De La Torre IG
Silvariño R
Manni JA
Durán-Barragán S
Vilá LM
Fortin PR
Calvo-Alén J
Santos MJ
Portela M
Esteva-Spinetti MH
Weisman M
Acevedo EM
Segami MI
Gentiletti SB
Roldán J
Navarro I
Gonzalez E
Liu JM
Karlson EW
Costenbader KH
Wolfe F
Alarcón GS
Source :
Lupus [Lupus] 2009 Oct; Vol. 18 (12), pp. 1033-52.
Publication Year :
2009

Abstract

We have previously developed and validated a self-administered questionnaire, modelled after the Systemic Lupus International Collaborating Clinics Damage Index (SDI), the Lupus Damage Index Questionnaire (LDIQ), which may allow the ascertainment of this construct in systemic lupus erythematosus (SLE) patients followed in the community and thus expand observations made about damage. We have now translated, back-translated and adapted the LDIQ to Spanish, Portuguese and French and applied it to patients followed at academic and non-academic centres in North and South America, Portugal and Spain while their physicians scored the SDI. A total of 887 patients (659 Spanish-speaking, 140 Portuguese-speaking and 80 French-speaking patients) and 40 physicians participated. Overall, patients scored all LDIQ versions higher than their physicians (total score and all domains). Infrequent manifestations had less optimal clinimetric properties but overall agreement was more than 95% for the majority of items. Higher correlations were observed among the Spanish-speaking patients than the Portuguese-speaking and French-speaking patients; further adjustments may be needed before the Portuguese and French versions of the LDIQ are applied in community-based studies. The relationship between the LDIQ and other outcome parameters is currently being investigated in a different patient sample.

Details

Language :
English
ISSN :
1477-0962
Volume :
18
Issue :
12
Database :
MEDLINE
Journal :
Lupus
Publication Type :
Academic Journal
Accession number :
19762375
Full Text :
https://doi.org/10.1177/0961203309105590